2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimi

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D23902

Patent

active

052200256

ABSTRACT:
The present invention is novel compounds which are 2-substituted amino-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are described as having activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever and the like. Thus, the present invention is also a pharmaceutical composition or method of manufacturing a pharmaceutical composition for the use of treating the noted conditions.

REFERENCES:
patent: 4554276 (1985-11-01), La Mattina
patent: 4711888 (1987-12-01), Walker et al.
patent: 4859679 (1989-08-01), Santini
patent: 4940712 (1990-07-01), Walker et al.
Bioch. J. 1951, 48, pp. 400-406.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1044279

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.